Outset Medical (OM) Total Debt Growth (3y) (2022 - 2026)
Outset Medical (OM) Total Debt Growth (3y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.03 Bn | 175.74 Bn | 6.27 Bn | 26.30% |
| 2 | Stryker | 129.38 Bn | 126.50 Bn | 3.81 Bn | 4.07% |
| 3 | Medtronic | 108.86 Bn | 99.64 Bn | 6.41 Bn | 4.70% |
| 4 | Boston Scientific | 68.57 Bn | 67.12 Bn | 3.61 Bn | 6.99% |
| 5 | Edwards Lifesciences | 47.66 Bn | 43.99 Bn | 1.29 Bn | 0.11% |
| 6 | Dexcom | 28.64 Bn | 27.52 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 28.55 Bn | 26.27 Bn | 1.98 Bn | -0.32% |
| 8 | Smith & Nephew | 27.02 Bn | 26.44 Bn | - | 5.42% |
| 9 | Koninklijke Philips | 25.54 Bn | 22.42 Bn | 2.07 Bn | 2.61% |
| 10 | Outset Medical | 77,625.92 | -286.57 Mn | 12.10 Mn | 0.16% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.16% |
| Dec 31, 2025 | -0.03% |
| Sep 30, 2025 | 47.40% |
| Jun 30, 2025 | 45.46% |
| Mar 31, 2025 | 46.74% |
| Dec 31, 2024 | 87.88% |
| Sep 30, 2024 | 87.86% |
| Jun 30, 2024 | 87.85% |
| Mar 31, 2024 | 87.84% |
| Dec 31, 2023 | 63.67% |
| Sep 30, 2023 | 48.34% |
| Dec 31, 2022 | 49.11% |